9:25 PM
 | 
Mar 28, 2007
 |  BC Extra  |  Company News

Merck, H. Lundbeck dropping gaboxadol

H. Lundbeck (CSE:LUN) fell DKK26.50 (17%) to DKK133 on Wednesday after it and partner MRK discontinued development of gaboxadol for insomnia....

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >